Effect of an Aldose Reductase Inhibitor on Alveolar Bone Loss Associated with Periodontitis in Diabetic Rats

References

• . Vernillo AT. Diabetes mellitus: relevance to dental treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91(3):263–270
   PubMed Web of Science ®Google Scholar
• . Moore PA, Guggenheimer J, Etzel KR, Weyant RJ, Orchard T. Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(3):281–291
   PubMed Web of Science ®Google Scholar
• . Sandberg GE, Wikblad KF. Oral dryness and peripheral neuropathy in subjects with type 2 diabetes. J Diabetes Complications. 2003;17(4):192–198
   PubMed Web of Science ®Google Scholar
• . Ramos-Remus C, Suarez-Almazor M, Russell AS. Low tear production in patients with diabetes mellitus is not due to Sjogren's syndrome. Clin Exp Rheumatol. 1994;12(4):375–380
   PubMed Web of Science ®Google Scholar
• . Carrington J, Getter L, Brown RS. Diabetic neuropathy masquerading as glossodynia. J Am Dent Assoc. 2001;132(11):1549–1551
   PubMed Web of Science ®Google Scholar
• . Brown RS, Farquharson AA, Sam FE, Reid E. A retrospective evaluation of 56 patients with oral burning and limited clinical findings. Gen Dent. 2006;54(4):267–271
   PubMedGoogle Scholar
• . Jordan RC. Diagnosis of periodontal manifestations of systemic diseases. Periodontol 2000. 2004;34:217–229
   PubMed Web of Science ®Google Scholar
• . Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol. 2001;6(1):91–98
   PubMedGoogle Scholar
• . Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366(9499):1809–1820
   PubMed Web of Science ®Google Scholar
• . Saremi A, Nelson RG, Tulloch-Reid M, . Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005;28(1):27–32
   PubMed Web of Science ®Google Scholar
• . Geismar K, Stoltze K, Sigurd B, Gyntelberg F, Holmstrup P. Periodontal disease and coronary heart disease. J Periodontol. 2006;77(9):1547–1554
   PubMed Web of Science ®Google Scholar
• . Pussinen PJ, Alfthan G, Rissanen H, Reunanen A, Asikainen S, Knekt P. Antibodies to periodontal pathogens and stroke risk. Stroke. 2004;35(9):2020–2023
   PubMed Web of Science ®Google Scholar
• . Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev. 2001;14(4):727–752
   PubMed Web of Science ®Google Scholar
• . Darre L, Vergnes JN, Gourdy P, Sixou M. Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab. 2008;34(5):497–506
   PubMed Web of Science ®Google Scholar
• . Lalla E, Lamster IB, Feit M, . Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest. 2000;105(8):1117–1124
   PubMed Web of Science ®Google Scholar
• . Naguib G, Al-Mashat H, Desta T, Graves DT. Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol. 2004;123(1):87–92
   PubMed Web of Science ®Google Scholar
• . Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2-way relationship. J Periodontol. 2003;74(1):97–102
   PubMed Web of Science ®Google Scholar
• . Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis–impact on periodontal pathology. J Dent Res. 2006;85(1):15–21
   PubMed Web of Science ®Google Scholar
• . Bosshardt DD, Lang NP. The junctional epithelium: from health to disease. J Dent Res. 2005;84(1):9–20
   PubMed Web of Science ®Google Scholar
• . Dumitrescu AL, Abd-El-Aleem S, Morales-Aza B, Donaldson LF. A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol. 2004;31(8):596–603
   PubMed Web of Science ®Google Scholar
• . Liu R, Bal HS, Desta T, . Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res. 2006;85(6):510–514
   PubMed Web of Science ®Google Scholar
• . Page RC, Schroeder H. Periodontisis in Man and Other Animals: A Comparative Review. Basel, Switzerland: Karger; 1982
   Google Scholar
• . Kador PF, Inoue J, Blessing K. Anticataract activity of analogs of a sorbitol dehydrogenase inhibitor. J Ocul Pharmacol Ther. 2004;20(4):333–344
   PubMed Web of Science ®Google Scholar
• . Kador PF, Inoue J, Secchi EF, . Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats. Exp Eye Res. 1998;67(2):203–208
   PubMed Web of Science ®Google Scholar
• . Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF. Permeability of the blood-retinal and blood-aqueous barriers in galactose-fed rats. J Ocul Pharmacol Ther. 1995;11(3):469–487
   PubMed Web of Science ®Google Scholar
• . Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats. J Ocul Pharmacol Ther. 2000;16(2):149–160
   PubMed Web of Science ®Google Scholar
• . Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF. Iris vasculopathy in galactose-fed rats. Exp Eye Res. 1999;68(2):211–221
   PubMed Web of Science ®Google Scholar
• . Zatechka DS Jr, Kador PF, Garcia-Castiñeiras S, Lou MF. Diabetes can alter the signal transduction pathways in the lens of rats. Diabetes. 2003;52(4):1014–1022
   PubMed Web of Science ®Google Scholar
• . Lou MF, Dickerson JE Jr, Chandler ML, Brazzell RK, York BM Jr. The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576. J Ocul Pharmacol. 1989;5(3):233–240
   PubMedGoogle Scholar
• . Crawford JM, Taubman MA, Smith DJ. The natural history of periodontal bone loss in germfree and gnotobiotic rats infected with periodontopathic microorganisms. J Periodontal Res. 1978;13(4):316–325
   PubMed Web of Science ®Google Scholar
• . Chung SS, Chung SK. Aldose reductase in diabetic microvascular complications. Curr Drug Targets. 2005;6(4):475–486
   PubMed Web of Science ®Google Scholar
• . Kador PF. The role of aldose reductase in the development of diabetic complications. Med Res Rev. 1988;8(3):325–352
   PubMed Web of Science ®Google Scholar
• . Oates PJ, Mylari BL. Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert Opin Investig Drugs. 1999;8(12):2095–2119
   PubMedGoogle Scholar
• . Kador PF. Ocular Pathology of Diabetes Mellitus. Doude's Foundations of Clinical Ophthalmology. Vol 3. In press
   Google Scholar
• . Chung SS, Chung SK. Genetic analysis of aldose reductase in diabetic complications. Curr Med Chem. 2003;10(15):1375–1387
   PubMed Web of Science ®Google Scholar
• . Demaine AG. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications. Curr Med Chem. 2003;10(15):1389–1398
   PubMed Web of Science ®Google Scholar
• . Oates PJ. Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol. 2002;50:325–392
   PubMed Web of Science ®Google Scholar
• . Robison WG. Galactosemic Animal Models. Amsterdam, The Netherlands: Harwood Academic Publishers; 2000
   Google Scholar
• . Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK. Aldose reductase mediates the mitogenic signals of cytokines. Chem Biol Interact. 2003;143–144:587–596
   PubMed Web of Science ®Google Scholar
• . Ramana KV, Srivastava SK. Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages. Cytokine. 2006;36(3–4):115–122
   PubMed Web of Science ®Google Scholar
• . Chandra D, Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK. Role of aldose reductase in TNF-alpha-induced apoptosis of vascular endothelial cells. Chem Biol Interact. 2003;143–144:605–612
   PubMed Web of Science ®Google Scholar
• . Pladzyk A, Reddy AB, Yadav UC, Tammali R, Ramana KV, Srivastava SK. Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells. Invest Ophthalmol Vis Sci. 2006;47(12):5395–5403
   PubMed Web of Science ®Google Scholar
• . Ramana KV, Bhatnagar A, Srivastava SK. Aldose reductase regulates TNF-alpha-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett. 2004;570(1–3):189–194
   PubMed Web of Science ®Google Scholar
• . Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem. 2002;277(35):32063–32070
   PubMed Web of Science ®Google Scholar
• . Cruz JW, Soto-Suazo MW, Hohman TC, Akamine EH, Zorn TT, Fortes ZB. Minalrestat and leukocyte migration in diabetes mellitus. Diabetes Metab Res Rev. 2003;19(3):223–231
   PubMed Web of Science ®Google Scholar
• . Fukase S, Sato S, Mori K, Secchi EF, Kador PF. Polyol pathway and NADPH-dependent reductases in dog leukocytes. J Diabetes Complications. 1996;10(6):304–313
   PubMed Web of Science ®Google Scholar
• . Hasegawa G, Obayashi H, Kitamura A, . Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy. Diabetes Res Clin Pract. 1999;45(1):9–14
   PubMed Web of Science ®Google Scholar
• . Ratliff DM, Vander Jagt DJ, Eaton RP, Vander Jagt DL. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II–a clinical research center study. J Clin Endocrinol Metab. 1996;81(2):488–492
   PubMed Web of Science ®Google Scholar
• . Awata T, Sogo S, Yamagami Y, Yamamoto Y. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats. J Ocul Pharmacol. 1988+;4(3):195–201
   PubMedGoogle Scholar
• . Datiles MB, Kador PF, Fukui HN, Hu TS, Kinoshita JH. Corneal re-epithelialization in galactosemic rats. Invest Ophthalmol Vis Sci. 1983;24(5):563–569
   PubMed Web of Science ®Google Scholar
• . Inaba M, Terada M, Nishizawa Y, . Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. Metabolism. 1999;48(7):904–909
   PubMed Web of Science ®Google Scholar
• . Inaba M. Effect of aldose reductase on the abnormality of calcium metabolism in diabetic patients [in Japanese]. Clin Calcium. 2006;16(8):1360–1365
   PubMedGoogle Scholar